The world's largest and most influential allergy, asthma and clinical immunology meeting. took place at the ICM between 26–30 May 2018. The satellite symposium ‘Global perspectives on chronic spontaneous urticaria (CSU) management: international recommendations vs. local practice’ can be found below, where our expert faculty, consisting of Marcus Maurer, Désirée Larenas-Linnemann, Elias Toubi and Zuotao Zhao discussed the latest revisions to CSU guidelines and explored regional variation in CSU treatment, comorbidities and retreatment.
Our faculty also answered every question submitted by the audience so scroll down to watch their opinions on skin prick testing, up-dosing with antihistamines, stopping third-line therapy and more or Click here for a full list of questions and answers.
During EAACI 2018, Uriach sponsored an expert-faculty-driven satellite symposium titled “The needs of allergic patients and how to address them”. Take a look at the content related to CSU from the symposium that was presented by Professor Masatoshi Abe.
Professor Masatoshi Abe highlights the recommendations for second-generation antihistamine use as well as the 2017 updates to the EAACI/GA2LEN/EDF/WAO treatment algorithm. This video was recorded at the Uriach-sponsored satellite symposium at EAACI 2018.
Professor Marcus Maurer gives an update on the 2017 guideline revision to highlight relevant changes for doctor and patient.
In part one of our case study, Marcus Maurer introduces Anna and describes her symptoms and previous treatment.
In part two of our case study, Marcus Maurer describes Anna’s diagnostic work-up which leads to a diagnosis of CSU with Hashimoto’s thyroiditis.
In part three of our case study, Marcus Maurer updates us on Anna’s treatment and how to monitor her symptoms.
In the final part of our case study, Marcus Maurer describes how despite responding well to third-line therapy, Anna’s symptoms returned once treatment was discontinued.
Our faculty answer audience questions regarding other therapies for CSU and guideline updates.